News

EQUATE has announced the beginning of commercial operations of The Kuwait Styrene Company’s (TKSC) new Ethyl Benzene & Styrene Monomer (EBSM) production plant. With a production capacity of

Aurobindo Pharma (Aurobindo) has reported that it will acquire Trident Life Sciences (TLSL) for an undisclosed amount. The company said that the board has approved the acquisition of

GlaxoSmithKline (GSK) and Genmab have provided top-line results from an international multi-center study of Arzerra (ofatumumab) in rituximab refractory follicular non-Hodgkin’s lymphoma (NHL). Reportedly, a total of 116

CDC Global Services, a wholly-owned subsidiary of CDC Corporation, has signed a binding term sheet to acquire an IT services provider primarily focused on business intelligence solutions for

China-Biotics has reported an increase in net sales during the first quarter of 2010 fiscal year by 35.5% to $15.4m, from $11.4m a year ago. Gross profit for

Gloucester has reported that it will discuss the New Drug Application for romidepsin to treat patients with cutaneous T-cell lymphoma (CTCL) at the Oncologic Drugs Advisory Committee (ODAC)

GeoPharma has reported a decrease in revenues for the first quarter of FY2010, to $5.2m, compared to $6.4m for the same period of FY2009. Overall Gross Profits from

AEterna Zentaris has reported phase 3 results for its North American efficacy trial – Z-033 and the safety trial – Z-041 in benign prostatic hyperplasia (BPH), with its

CSL Behring has announced that Helixate FS, Antihemophilic Factor (Recombinant), has been approved by the FDA. It is for routine prophylaxis in children with hemophilia A who are